2026 AGENDA + EVENTS
Texas Life Science Forum Agenda | Tuesday, Nov. 10, 2026
We're looking forward to seeing you at the 15th Annual Texas Life Science Forum!
-
-
John (J.R.) Reale, Executive Director, Rice Alliance for Technology and Entrepreneurship
Jeff Wade, Chairman, BioHouston
-
William McKeon, President and CEO, Texas Medical Center
-
Moderator: Annie Sendejo, Vice President, Life Sciences Banking, J.P. Morgan
Ankit Aggarwal, Executive Director, Healthcare Investment Banking, J.P. Morgan
Barbara Alcaraz Silva, PhD, Executive Director, National Head Life Sciences and Healthcare Startup Banking, J.P. Morgan -
- Orphagen Pharmaceuticals
- 4M Therapeutics
- CoRegen
- Branch Therapeutics
- Clear.bio
- Persevere Therapeutics
- Stingray Therapeutics
- PDX Pharmaceuticals
- CELLeBRAIN
- Neurovantix Therapeutics
-
Moderator: Mike Silliman, Partner, Baker Botts
Pothik Chatterjee, Executive Director, Digital Health Institute, Rice University and Methodist Hospital
Kalen Hall, PhD, CEO & Cofounder, Informuta, Inc.
Drew Yashar, Principal, Capital Factory -
-
Moderator: Jeff Wade, Chairman, BioHouston
Michael Torres, PhD, Founder and Former CEO of CrossBridge Bio
-
- Ansana
- Spatium Medical
- Magellan Biomedical
- Vertility Health
- Bairitone Health
- Aliform
- Implant Preservation Devices
- NovaScan
- Flux Robotics
-
Moderator: Pablo Lapuerta, MD, Chief Executive Officer, 4M Therapeutics
Hung-Kai Kevin Chen, MD, PhD, Founder & CEO, Elixiron Immunotherapeutics and NeuroVantix TherapeuticsJoshua Shulman, MD, PhD, Professor of Neurology, Neuroscience, and Molecular & Human Genetics, Baylor College of Medicine, Director of Baylor Center for Alzheimer’s and Neurodegenerative Diseases
Sudhir Sivakumaran, PhD, Chief Scientific Officer, Lewy Body Dementia Association -
Moderator: Michael King, Managing Director and Head of Research, Rodman & Renshaw
Chau Khuong, Founder and Chief Investment Officer, CJNV Bioventures
Tom Luby, PhD, Chief Innovation Officer, Texas Medical Center -
Moderator: Leah Goodman, CEO, Biointelect
Rahul Aras, PhD, President & CEO, Iterion Therapeutics
Sarah Hein, PhD, CEO & Co-Founder, March Biosciences
Pablo Lapuerta, MD, Chief Executive Officer, 4M Therapeutics -
-
Devin Dunn, Vice President, Innovation, TMC Innovation Factory
-
Moderator: David Schull, President, Russo Partners
Adam Matthews, Chief Executive Officer, Discover International
Leigh Steinberg, Chairman of the Board, Steinberg Sports and Entertainment -
Moderator: Ben Perkins, Founder & Managing Partner, pH Partners
David Gow, CEO, Center for Houston's Future -
- Akomera
- Cardiost
- Convergent Medical
- OptiLung
- Kallisio
- Imagine Devices
- ImmunoBreath
-
Brian Mayhew, Executive Vice President of Regulatory Policy, ELIQUENT Life Sciences
-
- OmniNano Pharmaceuticals
- PriveBio
- MusiQ Bio
- Avesta Bio
- Veneno Technologies
-
Gabriela de Almeida, PhD, Managing Director and Partner, Boston Consulting Group
-
Moderator: Jeff Wade, Chairman, BioHouston
Bruce Butler, PhD, Vice President, Research and Technology Director, Office of Technology Management, UT Health Houston
Papia Ghosh, PhD, Director, Business Development and Commercial Strategy, Strategic Industry Ventures, UT MD Anderson Cancer CenterVineet Gupta, PhD, Vice President for Innovation and Tech Development and Transfer, UTMB
Joseph Petrosino, PhD, Chief Scientific Officer, Baylor College of Medicine -
Michael Dilling, PhD, Executive Director, Commercialization & Technology Management, BCM Innovation Institute, Baylor College of Medicine
Dustin Edwards, Partner, Winston Taylor
Eric Johnson, Partner, Winston Taylor -
-
- Lactocyte Diagnostics
- NBCL BV
- Seluna
- Voxel Systems
- Delphi Diagnostics
- AmyGo Solutions
-
Moderator: Robert Suffoletta, Partner, Corporate and Securities, Wilson Sonsini
Aaron Schuchart, President and CEO, Aether Therapeutics
Leslie Sloan, PhD, CEO, OmniNano Pharmaceuticals
-
- NodoN
- NeuroHagana Ltd.
- Nemea Therapeutics
- Medley Therapeutics
- PaxImmune Therapeutics / MD Anderson
- Waventra Therapeutics
- Ambrosia Space
- Heliowave Technologies
- BioPure
-
Moderator: Adrian Trömel, Interim Vice President for Innovation and Chief Innovation Officer, Office of Innovation, Rice University
Kristen Doyle, Chief Executive Officer, Cancer Prevention and Research Institute of Texas
Steve Lehmann, Co-founder and Managing Partner, BCM Legacy Fund -
Arthur Sands, MD, PhD, President and CEO, Nurix Therapeutics
-
Ten Most Promising Life Science Companies
Presented by Monique Knighten, Executive Director, Life Science, Beacon CoLabMichael E. DeBakey Award - Presented by BioHouston
People’s Choice Award
-
HAN Life Science Kick-off Event | Monday Nov. 9, 2026
AI in the Clinical Space: From Innovation to Implementation
Join the Houston Angel Network on Monday, Nov. 9, 2026, from 4:00 to 8:00 PM at the Texas A&M School of Engineering and Medicine for our Life Science Kick-off Event. The evening includes HAN Portfolio Company Pitches, networking, three panels on AI in healthcare, and a keynote by Dr. Peter Pisters, M.D., former President of MD Anderson. You can register on Eventbrite and use code EARBRD for early bird pricing.
Envision 2026: Clinical Research, Reimagined | Wednesday, Nov. 11, 2026
Discover how clinical research is being reimagined at Envision 2026!
Envision focuses on advancing clinical research and accelerating the path from innovation to patient care. This year, we’re taking a closer look at what sets Houston apart as a hub for clinical research and how TMC is exploring strategies to address the roadblocks Houston and Texas face today when it comes to clinical trial efficiency.
In collaboration with leading TMC member institutions, including UT MD Anderson Cancer Center, Baylor College of Medicine, UTHealth Houston, UTMB Health, Houston Methodist, and partners across the broader healthcare ecosystem, we are bringing together researchers, clinicians, industry leaders, and investors, helping to advance first-in-human and early-stage clinical trials.